Pre-clinical and clinical data support a number of indications. They include Myasthenia Gravis, Hashimoto Disease, IBD (Crohn’s/Colitis), Multiple Sclerosis with further expansion to over 100 ultra-rare, rare and orphan diseases. Where IVIG is used we believe that ACT-101 will be effective.